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Loss of PLA2G6 leads to elevated mitochondrial
lipid peroxidation and mitochondrial
dysfunction
Kerri J. Kinghorn,1,2 Jorge Iva´n Castillo-Quan,1,2,3 Fernando Bartolome,2
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The PLA2G6 gene encodes a group VIA calcium-independent phospholipase A2 beta enzyme that selectively hydrolyses
glycerophospholipids to release free fatty acids. Mutations in PLA2G6 have been associated with disorders such as infantile
neuroaxonal dystrophy, neurodegeneration with brain iron accumulation type II and Karak syndrome. More recently, PLA2G6
was identiﬁed as the causative gene in a subgroup of patients with autosomal recessive early-onset dystonia-parkinsonism.
Neuropathological examination revealed widespread Lewy body pathology and the accumulation of hyperphosphorylated tau,
supporting a link between PLA2G6 mutations and parkinsonian disorders. Here we show that knockout of the Drosophila
homologue of the PLA2G6 gene, iPLA2-VIA, results in reduced survival, locomotor deﬁcits and organismal hypersensitivity to
oxidative stress. Furthermore, we demonstrate that loss of iPLA2-VIA function leads to a number of mitochondrial abnormalities,
including mitochondrial respiratory chain dysfunction, reduced ATP synthesis and abnormal mitochondrial morphology.
Moreover, we show that loss of iPLA2-VIA is strongly associated with increased lipid peroxidation levels. We conﬁrmed our
ﬁndings using cultured ﬁbroblasts taken from two patients with mutations in the PLA2G6 gene. Similar abnormalities were seen
including elevated mitochondrial lipid peroxidation and mitochondrial membrane defects, as well as raised levels of cytoplasmic
and mitochondrial reactive oxygen species. Finally, we demonstrated that deuterated polyunsaturated fatty acids, which inhibit
lipid peroxidation, were able to partially rescue the locomotor abnormalities seen in aged ﬂies lacking iPLA2-VIA gene function,
and restore mitochondrial membrane potential in ﬁbroblasts from patients with PLA2G6 mutations. Taken together, our ﬁndings
demonstrate that loss of normal PLA2G6 gene activity leads to lipid peroxidation, mitochondrial dysfunction and subsequent
mitochondrial membrane abnormalities. Furthermore we show that the iPLA2-VIA knockout ﬂy model provides a useful platform
for the further study of PLA2G6-associated neurodegeneration.
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Introduction
The PLA2G6 gene encodes an 85-kDa group VI calcium-
independent phospholipase A2 beta (PLA2G6). This
enzyme hydrolyses the sn-2 acyl chain of glycerophospho-
lipids to release free fatty acids and lysophospholipids
(Wolf and Gross, 1996; Ma and Turk, 2001). PLA2G6
localizes to the mitochondria, and has proposed roles in
the remodelling of membrane phospholipids, signal trans-
duction and calcium signalling, cell proliferation and apop-
tosis (Gadd et al., 2006; Seleznev et al., 2006; Strokin
et al., 2012).
Humans with PLA2G6 mutations can show progressive
cognitive and motor skill regression, as displayed in
disorders such as infantile neuroaxonal dystrophy, neurode-
generation with brain iron accumulation type II and Karak
syndrome (Khateeb et al., 2006; Morgan et al., 2006).
Infantile neuroaxonal dystrophy is a neurodegenerative
disease with onset in infancy and fatality in the teenage
years or in early adulthood. It is characterized neuropatho-
logically by axonal swelling and the presence of spheroid
bodies in the central and peripheral nervous systems in add-
ition to hallmark cerebellar atrophy. Neurodegeneration
with brain iron accumulation comprises a clinically and gen-
etically heterogeneous group of disorders with a progressive
extrapyramidal syndrome and high basal ganglia iron, and
includes pantothenate kinase-associated neurodegeneration
caused by mutations in PANK2 (neurodegeneration with
brain iron accumulation type I). Post-mortem examination
of the brain of a patient with neurodegeneration with brain
iron accumulation associated with homozygous PLA2G6
mutations demonstrated both Parkinson’s and Alzheimer’s
disease pathology with widespread Lewy bodies, dystrophic
neurites and cortical neuronal neuroﬁbrillary tangles
(Gregory et al., 2008).
Furthermore, PLA2G6 has also been implicated in a
number of other brain diseases including Alzheimer’s
disease (Schaeffer and Gattaz, 2008) and bipolar disorder
(Xu et al., 2013). More recently, PLA2G6, at the PARK14
locus, has also been characterized as the causative gene in a
subgroup of patients with autosomal recessive early-onset
dystonia-parkinsonism. Interestingly these patients did not
display cerebellar atrophy or basal ganglia iron on
MRI (Paisan-Ruiz et al., 2009), and neuropathological
examination revealed widespread Lewy body pathology
and the accumulation of hyperphosphorylated tau
(Paisan-Ruiz et al., 2012). These clinical and neuropatho-
logical features further support a link between PLA2G6
mutations and parkinsonian disorders, and demonstrate
the clinical heterogeneity in PLA2G6-associated
neurodegeneration.
It is not known how mutations in PLA2G6 cause neuro-
pathology. However, it has been suggested that the loss of
normal PLA2G6 activity in neurodegenerative disease
involves structural abnormalities of cell or mitochondrial
membranes and disturbances in lipid homeostasis and
lipid metabolism. Indeed, a study in a mouse Pla2g6
knockout model demonstrated ultrastructural abnormalities
in mitochondrial and synaptic membranes (Beck et al.,
2011). As well as possible mitochondrial defects, it is
thought that changes in the composition of the plasma
membrane and other intracellular membranes may in turn
affect the normal processes responsible for the movement
of membranes within axons and dendrites, subsequently
leading to accumulation of membranes as so-called
spheroids.
Support for a loss-of-function of PLA2G6 enzyme activ-
ity in causing disease comes from a recent study on recom-
binant wild-type and mutant human PLA2G6 proteins.
This demonstrated that mutations in PLA2G6 associated
with infantile neuroaxonal dystrophy or neurodegeneration
with brain iron accumulation resulted in encoded proteins
that exhibited 520% of control levels of phospholipase
and lysophospholipase activities. Conversely, mutations
associated with dystonia-parkinsonism did not impair
catalytic activity. The differential enzymatic activities asso-
ciated with PLA2G6 mutations in infantile neuroaxonal
dystrophy/neurodegeneration with brain iron accumulation
and dystonia-parkinsonism may explain the relatively later
onset and milder phenotype seen in the latter. Furthermore,
the preserved enzymatic function of dystonia-parkinsonism
causing mutations must be interpreted with caution as there
may be differences in PLA2G6 activity in vivo that are not
detected by these in vitro assays. For example, there may be
alternative mechanisms that alter the regulation of PLA2G6
activity, such as changes in the binding to calmodulin or
other proteins (Engel et al., 2010). Further support for the
loss of enzymatic function hypothesis comes from a recent
study of a Chinese population with Parkinson’s disease,
which identiﬁed novel PLA2G6 mutations occurring in
the heterozygous state, associated with an inhibition
in the phospholipid-hydrolysing functions of PLA2G6
(Gui et al., 2013). Moreover Gregory et al. (2008) found
a genotype–phenotype correlation in patients with infantile
neuroaxonal dystrophy and neurodegeneration with brain
iron accumulation: mutations that are predicted to lead to
an absence of protein were associated with more severe
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infantile neuroaxonal dystrophy-type clinical phenotypes,
while those with compound heterozygous missense muta-
tions correlated with the less severe phenotype of neurode-
generation with brain iron accumulation and are
predicted to result in protein with some residual enzyme
function.
Genetic ablation of Pla2g6 in mice is associated with an
in vivo disturbance of brain phospholipid metabolism
(Cheon et al., 2012), mitochondrial membrane degener-
ation (Beck et al., 2011) and marked cerebellar atrophy
(Zhao et al., 2011). Furthermore, in vitro experiments
demonstrated a disturbance in calcium signalling in astro-
cytes from PLA2G6-deﬁcient mice (Strokin et al., 2012).
However, despite these studies, the precise molecular mech-
anisms linking loss of PLA2G6 activity to mitochondrial
morphological abnormalities and neurodegeneration
remain unclear and further studies are required.
The fruit ﬂy Drosophila melanogaster has proven to be
an excellent model system for studying neurodegenerative
diseases, especially the role of mitochondrial activity in
Parkinson’s disease (Clark et al., 2006; Park et al., 2006).
Once a faithful model is established, the ﬂy has the advan-
tage over mouse models in that it can be used to perform
high-throughput screening to identify genetic modiﬁers and
novel therapeutic targets. Here we show that iPLA2-VIA,
the Drosophila homologue of PLA2G6, plays an essential
role in maintaining normal mitochondrial function.
We demonstrate that knockout of the iPLA2-VIA gene
activity in the ﬂy results in reduced survival, locomotor
deﬁcits and organismal hypersensitivity to oxidative stress.
Furthermore, loss of iPLA2-VIA function leads to a
number of mitochondrial abnormalities, including reduced
mitochondrial membrane potential, mitochondrial respira-
tory chain dysfunction and reduced ATP synthesis. We also
show that levels of lipid peroxidation are signiﬁcantly
elevated in the brains of ﬂies lacking iPLA2-VIA. In add-
ition, we examined cultured ﬁbroblasts taken from two
patients with known PLA2G6 mutations and found similar
abnormalities to those seen in the ﬂy, including mitochon-
drial membrane abnormalities and raised levels of cytoplas-
mic and mitochondrial reactive oxygen species. Moreover,
lipid peroxidation levels, especially in the mitochondria,
were elevated in the PLA2G6 mutant human ﬁbroblasts
compared to controls. Taken together, our ﬁndings suggest
that loss of normal PLA2G6 gene activity leads to mito-
chondrial lipid peroxidation, mitochondrial dysfunction
and mitochondrial membrane abnormalities. Finally we
demonstrate that reduction of lipid peroxidation, by treat-
ment with deuterated polyunsaturated fatty acids
(D-PUFAs), is able to recover the mitochondrial
membrane potential of PLA2G6 mutant human ﬁbroblasts
and partially rescue the locomotor deﬁcits in iPLA2-
VIA knockout ﬂies. We have therefore shown that
the iPLA2-VIA knockout ﬂy appears to be a useful
model organism for studying PLA2G6-associated
neurodegeneration.
Materials and methods
Fly stocks and husbandry
The ﬂy stocks y[1] w[67c23]; P{w[ +mC]
y[ +mDint2]=EPgy2}iPLA2-VIA[EY05103], actin-5C-GAL4,
elav-GAL4c155 were obtained from the Bloomington
Drosophila Stock Centre. The iPLA2-VIA RNAi
(HMS01544) line was provided by the TRiP at Harvard
Medical School. All ﬂy strains used were backcrossed at least
six generations into the w1118 background to obtain isogenic
lines. All ﬂy stocks were maintained at 25C on a 12:12 hour
light: dark cycle at constant humidity on a standard
sugar-yeast (SY) medium (15 g/l agar, 50 g/l sugar, 100 g/l
autolysed yeast, 100 g/l nipagin and 3ml l/ propionic acid).
For all experiments, ﬂies were raised at a standard density
on standard SY medium in 200ml bottles unless otherwise
stated. Tissue-speciﬁc expression of iPLA2-VIA RNAi
constructs was achieved by using the GAL4-UAS system
[GAL4-dependant upstream activator sequence (Brand and
Perrimon, 1993)].
Lifespan analyses
The survival assays were performed using newly eclosed ﬂies
that were allowed to mature and mate for 24 h before the
females and males were separated and collected. One hundred
and ﬁfty ﬂies were housed in groups of 15 and the ﬂies were
transferred every 2 to 3 days onto fresh food and the number
of dead ﬂies recorded. Data are presented as cumulative
survival curves, and survival rates were compared using log-
rank tests.
Climbing assays
The climbing assay was performed using a negative geotaxis
assay according to previously published methods (Rival et al.,
2004). Brieﬂy, 15 adult ﬂies were placed in a vertical column
(25ml tissue culture pipette), and allowed to climb for 45 s
before the number of ﬂies at the top and bottom was deter-
mined. A performance index (PI) deﬁned as 0.5(n(total) +
n(top)  n(bottom)/ n(total)) was calculated. The experiment
was repeated three times for each time point.
Fertility tests
For female fecundity tests, female ﬂies were housed with males
for 48 h post-eclosion and then separated into vials at a density
of 10 females per vial. Eggs were collected over a 24-h period
at different time points. The number of eggs laid per vial at
each time point was counted.
Quantitative RT-PCR
Total RNA was extracted from 15 ﬂies per sample using
TRIzol (GIBCO) according to the manufacturer’s instruc-
tions. The concentration of total RNA puriﬁed for each
sample was measured using an Eppendorf biophotometer.
One microgram of total RNA was then subjected to DNA
digestion using DNase I (Ambion), immediately followed by
reverse transcription using the SuperScript II system
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(Invitrogen) with oligo(dT) primers. Quantitative PCR was
performed using the PRISM 7000 sequence-detection system
(Applied Biosystems), SYBR Green (Molecular Probes),
ROX Reference Dye (Invitrogen), and HotStarTaq (Qiagen)
by following the manufacturer’s instructions. Each sample
was analysed in triplicate with both target gene (iPLA2-VIA)
and reference gene (RP49) primers in parallel. The end
products of the RT-PCR reactions were also visualized by
staining with ethidium bromide following separation with
agarose-gel electrophoresis. The primers for the Drosophila
iPLA2-VIA used in the RT-PCR of the EY05103 ﬂy line
were as follows: forward 5’-TACTGGAATTGTGCGATAA
GG-‘3 and reverse 5’-GATGTGGTATTGGAATCCGAG-‘3.
The primers used for the RT-PCR performed on the
iPLA2-VIA RNAi (HMS01544) ﬂy line were as follows:
forward 5’- AACtriacylglycerolTAGTGCCGATCGTCCAA-‘3
and reverse 5’-GAACCAGTATCCTTGCAGCG-‘3. The refer-
ence gene primers were as follows: forward 5’-ATGACCAT
CCGCCCAGCATCAGG-‘3 and reverse 5’-
ATCTCGCCGCAGTAAACG-‘3.
Stress experiments
For all stress assays, ﬂies were reared and housed as for life-
span experiments. For oxidative stress assays, 7-day or 15-day
old ﬂies were transferred onto 5% sucrose/agar containing 5%
hydrogen peroxide (Sigma) or 20mM paraquat (Sigma). For
starvation and osmotic stress experiments, 7-day or 15-day old
ﬂies were transferred to 1% agar or 500mM NaCl respect-
ively. For hypoxia experiments 15-day old ﬂies were trans-
ferred to a hypoxia chamber with oxygen levels of 7%.
After 15 h the ﬂies were removed from the chamber and the
number of dead ﬂies was counted.
Triacylglyceride and ATP assays
Levels of triacylglyceride in adult females were measured using
the Triglyceride Inﬁnity Reagent (ThermoScientiﬁc) and nor-
malized to total body protein using a BCA assay (Sigma). The
ATP concentration of whole female ﬂies was determined using
the Roche ATP Bioluminescence Assay Kit HS II (Roche).
Brieﬂy, two live whole ﬂies or eight ﬂy heads were homoge-
nized in 100ml ice-cold lysis buffer (provided in the kit) for
1min using a Kontes pellet pestle. The lysate was then boiled
for 5min and centrifuged at 20 000g for 1min. 2.5 ml of
cleared lysate was added to 187.5 ml dilution buffer and
10 ml luciferase and the luminescence was immediately mea-
sured using a Tecan Inﬁnite M2000 microplate reader and
Magellan V6.5 software. Each reading was converted to the
amount of ATP per ﬂy based on the standard curve generated
with ATP standards. At least three measurements were made
for each genotype and the experiment was repeated three
times.
Isolation of Drosophila mitochondria
Fly mitochondria were isolated by differential centrifugation,
essentially as described in Miwa et al. (2003). Brieﬂy, adult
ﬂies (n = 500 for each time point) were chilled on ice and
gently pressed using a pre-chilled pestle and mortar.
Importantly, the pestle was moved in a vertical motion (with
no horizontal motion) until the shape of the ﬂies was no longer
visible. The ﬂies were then washed in STE + BSA buffer
[250mM sucrose, 5mM Tris, 2mM EGTA, pH 7.4 (4C),
1% bovine serum albumin]. The ﬂies were then pressed further
in 5ml of STE + BSA buffer. The squashed ﬂies were then
passed through double-layered muslin cloth. The collected
pulp was then spun for 3min at 4C at 1500 rpm to remove
debris. The supernatant was then passed through a single layer
of muslin into a clean centrifuge tube and spun for 10min at
4C and 10 000 rpm to collect the mitochondria. The mito-
chondrial pellet was then suspended in 250ml STE + BSA
buffer and stored on ice. A BCA assay (Sigma) was used to
determine the protein concentration of the mitochondrial prep-
arations. The isolated mitochondria were kept on ice and used
immediately for experiments.
Drosophila mitochondrial respiration
measurement
Oxygen consumption was measured using a Clark-type oxygen
electrode thermostatically maintained at 25C. Glutamate
(5mM) and malate (5mM) or pyruvate (5mM) were added
to measure Complex I-linked respiration, and succinate
(5mM) with rotenone (5 mM) were added to measure
Complex II-linked respiration. All data were obtained using
an Oxygraph Plus system with Chart recording software.
Light and electron microscopy of fly
brains
Flies were decapitated and the proboscis was removed to allow
penetration of the ﬁxative. The heads were perfused with 3%
glutaraldehyde in phosphate buffer overnight. Brains were then
treated with 1% osmium tetroxide for 3 h at 4C and
embedded in Araldite CY212 resin. Thin sections were
stained with toluidine blue and the brain visualized with the
light microscope. Ultrathin sections (70 mm) were stained with
lead citrate and uranyl acetate and digital images taken on a
Phillips CM10 electron microscope with a Megaview III digital
camera (Olympus).
Human fibroblast collection and
culture
The p.R747W PLA2G6 ﬁbroblasts were generated from a
4mm skin punch biopsy taken under local anaesthetic.
Biopsies were dissected into 1mm pieces and cultured in
5 cm petri dishes in Dulbecco’s modiﬁed Eagle’s medium
(DMEM), 10% foetal bovine serum, 1% L-glutamine until
ﬁbroblasts were seen to grow out from the explants. When
ﬁbroblasts reached conﬂuency, they were detached from cul-
ture dishes using TrypleETM (Invitrogen) and transferred to
larger culture vessels for further expansion and cryopreserva-
tion. This sample was collected with the written consent of the
participant and formal ethical approval from the National
Hospital for Neurology and Neurosurgery–Institute of
Neurology Joint Research Ethics Committee (London, UK).
The GM11529 mutant PLA2G6 human ﬁbroblast cell cultures
were obtained from the Coriell Cell Repositories. This line was
sampled from a patient with infantile neuroaxonal dystrophy.
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Fibroblasts were seeded at a density of 4  104 cells/cm2,
grown to 75–80% conﬂuence and maintained at 37C and
5% CO2 in DMEM supplemented with 10% (v/v) foetal
bovine serum, 2mM L-glutamine and 1% (v/v) penicillin/
streptomycin.
Measurement of mitochondrial
membrane potential and cytosolic
and mitochondrial reactive oxygen
species
For measurements of mitochondrial membrane potential
(m), dissected ﬂy brains or cells were loaded with 25 nM
tetramethylrhodamine methylester (TMRM) for 30min at
room temperature and the dye was present for the duration
of the experiment. TMRM is used in the redistribution mode
to assess m, and therefore a reduction in TMRM ﬂuores-
cence represents depolarization.
Confocal microscopy of
mitochondrial membranes in fly
brains and human fibroblasts
Confocal images were obtained using a Zeiss 710 VIS CLSM
equipped with a META detection system and a 40 oil
immersion objective. Illumination intensity was kept to a
minimum (at 0.1–0.2% of laser output) to avoid phototoxicity
and the pinhole set to give an optical slice of 2mm.
TMRM was excited using the 560 nm laser line and ﬂuores-
cence measured above 580 nm. All data presented were
obtained from at least ﬁve coverslips and two to three
different cell preparations for cell experiments, and
six coverslips and at least six counts for ﬂy brain
experiments. The same anatomical area of the ﬂy brain was
used each time.
Measurement of reactive oxygen
species levels in human fibroblasts
For measurement of mitochondrial reactive oxygen species
production, cells were preincubated with 5mM MitoSOXTM
(Molecular Probes) for 10min at room temperature.
Cytosolic reactive oxygen species generation was measured
with 2mM dihydroethidium with the dye present in all solu-
tions throughout the duration of the experiment.
Fluorescence images were obtained on an epiﬂuoresence
inverted microscope equipped with a 20 ﬂuorite objective
(Cairn Research). Ratiometric dihydroethidium and
MitoSOX ﬂuorescence was recorded with an excitation light
at 380 and 530nm and emission at 440 and 630nm,
respectively.
Measurement of lipid peroxidation in
fly brains and human fibroblasts
C11-BODIPY581/591 (Molecular Probes) is a sensitive ﬂuor-
escent probe for indexing lipid peroxidation in model mem-
brane systems and living cells undergoing a shift from red to
green ﬂuorescence emission upon oxidation, even under
physiological oxidation (Vaarmann et al., 2010). Fly brains
were dissected in phosphate-buffered saline and placed into
Hank’s balanced salt solution (HBSS). C11-BODIPY581/591
(5 mM) was loaded for 15min at 20C. Coverslips were
washed once and resuspended in 1ml of HBSS. Ratiometric
measurements of probe oxidation were taken over a 12min
time course. Fluorescence excitation was at 488 nm, green
ﬂuorescence was detected at 530 nm and red ﬂuorescence at
670 nm.
Cardiolipin analysis by mass
spectrometry
Cardiolipin and oxidized cardiolipin were measured by mass
spectrometry essentially as described previously (Pope et al.,
2008; Heather et al., 2010; Rodriguez-Cuenca et al., 2010)
with some minor modiﬁcations to make the analysis speciﬁc
for Drosophila cardiolipin species. In brief, 500 ﬂies of each
genotype were homogenized in NaPi buffer (50mM NaPi,
1mM EDTA, 100mM DTPA, pH 7.5) using a Kontes pellet
pestle. The homogenates were then spun for 2min at
13 000 rpm to remove ﬂy debris. Lipids were extracted using
a modiﬁed Folch extraction and the combined organic layers
were evaporated to dryness under nitrogen. Before analysis,
samples were resuspended in 1ml of a 1:1 mix of buffers
A and B (buffer A, 15% water, 85% methanol containing
1ml of 250ml/l aqueous ammonia per litre; buffer B, 97%
chloroform, 3% methanol containing 0.1ml of 250ml/l aque-
ous ammonia per litre). 1 nmol of (C14:0)4-cardiolipin (Avanti
Polar Lipids) was used as an internal standard and was added
to Drosophila head homogenates.
The LC/MS/MS system (Waters 2795 separation unit and a
Quattro Micro API triple quadrupole mass spectrometer) and
parameters were as described previously (Heather et al., 2010;
Rodriguez-Cuenca et al., 2010) except that the multiple
reaction monitoring (MRM) transitions were speciﬁc for
Drosophila cardiolipin. Mass spectra from retention times
5.5–6.0min were combined to generate cardiolipin spectra.
Cardiolipin species were identiﬁed in MRM mode with the
collision gas at 0.25 Pa and collision energy at 35 eV.
Cardiolipin species were analysed as their dianions
[CL–2H]2. In these samples, the dominant form of
cardiolipin was (C16:1)4-cardiolipin (m/z 671), which was
therefore selected for analysis based on its fragmentation to
a C16:1 fatty acid (m/z 253) by monitoring the
6714253 transition. Similarly, other cardiolpin species
(C18:2)1(C16:1)3-cardiolipin (m/z 684) and (C18:2)2
(C16:1)2-cardiolipin (m/z 697) were analysed by assessing
transitions of 6844253 and 6974253, respectively.
Oxidized cardiolipin was analysed by the transitions
6784253 and 6914253 transition. The internal standard
(C14:0)4-cardiolipin (m/z 619) was analysed by its fragmenta-
tion to a C14:0 fatty acid (m/z 227) using the transition
6194227. Data were analysed with QuanLynx software
(Waters). Total cardiolipin content was expressed as peak
area relative to that of the internal standard. The amounts
of each cardiolipin and oxidized cardiolipin were expressed
relative to the total amount of cardiolipin in the sample,
giving dimensionless ratios.
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Deuterated polyunsaturated fatty
acids
Deuterated polyunsaturated fatty acids (D-PUFAs)
11,11-D2-linoleic acid (D2-linoleic acid) and 11,11,14,
14-D4--linolenic acid (D4-linoleic acid) were kindly provided
by Dr Mikhail S. Shchepinov (Retrotope, Inc), and their
synthesis has been previously described (Hill et al., 2012).
Hydrogenated polyunsaturated fatty acids (H-PUFAs) were ob-
tained from Sigma–Aldrich (99%). Cells were preincubated
with 10 mM H- or D-PUFA (D4-linoleic acid) in the culture
media for 24 h and then washed with HBSS before experi-
ments. For the ﬂy experiments, D2-linoleic acid was diluted
in water and added to the standard ﬂy medium to give a
ﬁnal concentration of 10 or 100 mM.
Statistics
Data were expressed as means  standard error of the mean
(SEM). Signiﬁcant differences were evaluated by unpaired two-
tailed Student’s t-test and signiﬁcance levels are described in
individual ﬁgure legends. Climbing assays were analysed using
a two-way ANOVA or a one-way ANOVA with Bonferroni
correction.
Results
Drosophila lacking iPLA2-VIA activity
display age-dependent locomotor
deficits and reduced lifespan
A null mutant ﬂy stock completely lacking the Drosophila
orthologue of the PLA2G6 gene, iPLA2-VIA, was obtained
from the Bloomington Drosophila Stock Centre. We will
refer to null mutant ﬂies lacking both iPLA2-VIA genes
as iPLA2-VIA / henceforth. This ﬂy strain carries a
P-element insertion (EY05103) in the iPLA2-VIA gene
(Fig. 1A). As previously shown, RT-PCR analysis con-
ﬁrmed that there was complete knockout of iPLA2-VIA
gene expression in this strain with no detectable SYBR
green signal produced. The end products of the RT-PCR
reactions were also visualized on agarose gel electrophor-
esis, which conﬁrmed the complete absence of iPLA2-VIA
gene expression in the iPLA2-VIA / ﬂies (Fig. 1B)
(Malhotra et al., 2009). Knockout of iPLA2-VIA activity
in the ﬂy did not produce any gross changes in body size or
obvious differences in morphology (data not shown).
iPLA2-VIA is expressed throughout the adult ﬂy body,
including the brain and eye. The iPLA2-VIA gene displays
good homology with the human PLA2G6 gene, with a
51% identity and 67% positivity (FlyBase).
The iPLA2-VIA / ﬂies displayed progressive locomotor
deﬁcits, with the climbing ability of iPLA2-VIA / ﬂies in
response to light tapping progressively falling below that
of w1118 controls from 20 days of age (Fig. 1C).
Accompanying this climbing defect the iPLA2-VIA /
ﬂies also showed an 50% reduction in lifespan, in both
females (Fig. 1D) and males (Supplementary Fig. 1A).
Furthermore, ﬂies heterozygous for the EY05103 P-element
insertion (iPLA2-VIA), with presumed 50% gene activity
only, did not display reduced survival (Fig. 1D and
Supplementary Fig. 1A). To ensure that the reduced life-
span was, indeed, due to the EY05103 P-element insertion,
we generated ﬂies with precise excisions of the P-element,
by introducing a transposase in an appropriate cross, and
found that this restored a normal lifespan (Supplementary
Fig. 1B).
To conﬁrm the effect of iPLA2-VIA deﬁciency in the ﬂy,
we also inhibited iPLA2-VIA gene expression by transgenic
RNA interference (RNAi) technology, using the GAL4/UAS
system (Brand and Perrimon, 1993). Ubiquitous expression
of iPLA2-VIA dsRNAi (UAS-iPLA2-VIA-RNAi) with the
actin-GAL4 driver resulted in a 40% reduction in whole
body iPLA2-VIA gene expression using RT-PCR analysis
(Supplementary Fig. 1C). This reduction was associated
with an age-dependent decrease in climbing ability
(Fig. 1E) and a shortened lifespan (Fig. 1F). It can therefore
be robustly concluded that genetic inactivation of iPLA2-
VIA activity results in progressive locomotor deﬁcits and a
reduction in lifespan in Drosophila. To determine whether
these phenotypes were speciﬁc to loss of iPLA2-VIA
activity in the brain, we knocked down iPLA2-VIA in ﬂy
neural tissue using UAS-iPLA2-VIA-RNAi driven by the
elavc155-Gal4 driver. We observed a signiﬁcant reduction
in lifespan in these ﬂies (Fig. 1G), conﬁrming the brain-
speciﬁc effects of iPLA2-VIA deﬁciency.
We also assessed the fecundity of iPLA2-VIA / female
ﬂies. The number of eggs laid per female signiﬁcantly
declined with age compared with age-matched w1118 con-
trol ﬂies, and by Day 25 the null mutant ﬂies were almost
completely infertile (Supplementary Fig. 1D).
Brains lacking iPLA2-VIA display
severe, widespread neurodegeneration
and mitochondrial degeneration
Light microscopic examination of thin parafﬁn sections of
iPLA2-VIA / ﬂy brain revealed normal brain architecture
in young Day 2 ﬂies that was indistinguishable from w1118
controls (Fig. 2A and B). However, by Day 32 there was
signiﬁcant widespread vacuolation in the iPLA2-VIA / ﬂy
brains that was not present in w1118 control ﬂies (Fig. 2C
and D). Ultrastructural examination using electron micros-
copy revealed that the mitochondria were grossly abnormal
and swollen with fragmented cristae in aged Day
32 iPLA2-VIA / ﬂy brains as compared to the mitochon-
dria in age-matched w1118 control brains (Fig. 2E–H) or
younger Day 2 iPLA2-VIA / ﬂies (data not shown),
which were both ﬁlled with densely packed cristae.
Furthermore, examination of the ﬂy eye using electron mi-
croscopy revealed abnormal retinal structure in the aged
Day 32 iPLA2-VIA / ﬂies compared with age-matched
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control ﬂies, with grossly abnormal ommatidial structure
(Supplementary Fig. 2A and B).
Loss of iPLA2-VIA resulted in reduced
mitochondrial membrane potential
and abnormal mitochondrial
respiratory chain activity
Given the abnormal mitochondrial membrane morphology
in older iPLA2-VIA / ﬂies, we investigated whether loss
of iPLA2-VIA affected mitochondrial membrane potential
(m), an indicator of mitochondrial health and function.
Mitochondrial membrane potential was assessed in the
brains of 25-day-old ﬂies using TMRM ﬂuorescence and
imaging with confocal microscopy. This revealed a signiﬁ-
cant reduction in mitochondrial membrane potential in
iPLA2-VIA / ﬂy brains compared to controls (Fig. 3A).
We next isolated mitochondria from iPLA2-VIA / ﬂies
and assessed respiratory chain activity by measuring
oxygen consumption using a Clark-type oxygen electrode.
The steps in respiration were compared in mitochondria
isolated from iPLA2-VIA / ﬂies and control w1118 ﬂies
with substrates and inhibitors speciﬁc to individual respira-
tory complexes. We found that knockout of iPLA2-VIA
activity conferred a decrease in complex I and II-dependent
respiration (Fig. 3B), manifested as signiﬁcantly decreased
oxygen consumption in state 3 respiration, whether using
substrates for complex I (5mM glutamate and 5mM
malate) or for complex II (5mM succinate in the presence
of rotenone) (Fig. 3B). The respiratory control ratio is
the ratio of state 3 respiration (ADP stimulated) to state
4 respiration (no ADP present), and is considered an indi-
cation of the degree of coupling of mitochondrial respira-
tory chain activity to oxidative phosphorylation (Chance
and Williams, 1955). The respiratory control ratio was sig-
niﬁcantly lower in iPLA2-VIA / mitochondria compared
with age-matched control w1118 ﬂies (Fig. 3C), because of
Figure 1 Lack of iPLA2-VIA gene activity leads to reduced survival and locomotor deficits. (A) Schematic of the Drosophila iPLA2-VIA
gene, showing the position of the P-element insertion (arrowhead). The iPLA2-VIA gene has four main transcripts: iPLA2-VIA-RB, iPLA2-VIA-RC, iPLA2-
VIA-RD and iPLA2-VIA-RA (FlyBase). The position of the primers has been previously shown (Malhotra et al., 2009). (B) RT-PCR analysis of iPLA2-
VIA / flies shows that there is no mRNA expression of the iPLA2-VIA gene compared with w1118 control flies. The end products of the RT-PCR
reaction were run on an agarose gel. RP49 is an internal control gene and is expressed in both the iPLA2-VIA / and control w1118 flies. (C) iPLA2-
VIA / flies display an age-dependent reduction in climbing ability compared with w1118 controls (n = 45 flies per genotype, three repeats per
genotype, P5 0.05). Climbing ability is expressed as a perfomance index (PI) over time in days (d). (D) Female flies lacking both iPLA2-VIA genes
(iPLA2-VIA /) have a significantly reduced lifespan compared with w1118 control flies (P5 0.0001). Furthermore female flies lacking only one
iPLA2-VIA gene (iPLA2-VIA+ /; n = 150 flies per genotype) do not display a reduction in lifespan. (E) Ubiquitous downregulation of iPLA2-VIA
activity using sRNAi (UAS-iPLA2-VIA-RNAi) driven by Act5c-Gal4 (Act5c-Gal44UAS-iPLA2-VIA-RNAi) results in an age-dependent reduction in
climbing ability compared with control UAS-iPLA2-VIA-RNAi flies (P5 0.05; n = 45 flies per genotype, three repeats each). (F) Knockdown of
iPLA2-VIA activity using iPLA2-VIA sRNAi (UAS-iPLA2-VIA-RNAi) driven ubiquitously by Act5c-Gal4 (Act5c-Gal44UAS-iPLA2-VIA-RNAi) results in a
decrease in lifespan compared with control non-expressing UAS-iPLA2-VIA-RNAi flies (P5 0.0001) or driver Act5c-Gal4 flies (P5 0.0001), similar to
that seen with the null mutant flies (iPLA2-VIA /; n = 150 flies per genotype). (G) Knockdown of iPLA2-VIA activity using sRNAi (UAS-iPLA2-
VIA-RNAi) driven in the fly nervous system using the elav-Gal4 driver results in a decrease in lifespan compared with control non-expressing
UAS-iPLA2-VIA-RNAi flies (P5 0.0001), or driver elav-Gal4 (P5 0.0001; n = 150 flies per genotype), similar to that seen with the null mutant flies
(iPLA2-VIA /).
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Figure 2 Fly brains lacking iPLA2-VIA display severe mitochondrial degeneration at the ultrastructural level. (A) Light microsopic examin-
ation of Day 2 w1118 control (scale bar = 20mm) and (B) iPLA2-VIA / fly brains (scale bar = 30mm). (C) At Day 32 w1118 control fly brains display healthy
brain tissue compared with (D) iPLA2-VIA / flies brains, which display widespread vacuolation (arrows) (60 magnification; scale bars 20 = mm). (E and F)
Ultrastructural examination of aged Day 32 w1118 control fly brains (2500; scale bar = 0.6mm and  5300; scale bar = 0.2 mm) revealed normal mito-
chondrial morphology, which is in contrast to (G and H) Day 32 iPLA2-VIA / fly brains, which display significant degeneration of the mitochondrial cristae
(3100; scale bar = 0.5 mm and  5300; scale bar = 0.2 mm). Images representative of six fly brains examined for each genotype. No abnormal mitochondria
were seen in the w1118 control fly brains.
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the inhibition of state 3 respiration. Furthermore, the re-
spiratory control ratio of iPLA2-VIA / ﬂies in the pres-
ence of glutamate/malate was dependent on the age of the
ﬂies: older ﬂies having lower respiratory control ratio
values (Fig. 3C). Thus, loss of iPLA2-VIA activity reduces
mitochondrial membrane potential as a result of mitochon-
drial uncoupling, which increases with age in the iPLA2-
VIA / ﬂies.
Loss of iPLA2-VIA activity results in
reduced ATP levels and increased
sensitivity to oxidative stress
In keeping with the mitochondrial dysfunction caused by
loss of iPLA2-VIA activity, we also demonstrated that ATP
levels in aged, Day 25, iPLA2-VIA / ﬂy heads were
reduced by 40% compared with control ﬂies (Fig. 4A).
Levels were also reduced in whole iPLA2-VIA / ﬂies
compared with controls (Supplementary Fig. 3A).
Mitochondrial dysfunction can lead to decreased resist-
ance to reactive oxygen species, which has been implicated
in many neurodegenerative diseases. To explore the role of
iPLA2-VIA in resistance to oxidative stress, we examined
the survival of iPLA2-VIA / ﬂies after exposure to the
potent oxidizer hydrogen peroxide and paraquat, a free
radical generator. Consistent with the structural mitochon-
drial abnormalities in aged ﬂies, iPLA2-VIA / ﬂies
showed an age-dependent, mild sensitivity at Day 15 to
hydrogen peroxide and, more so, to paraquat (Fig. 4B
and C) that was not consistently present in younger
7-day-old ﬂies (data not shown). Both young Day 7 and
older Day 15 iPLA2-VIA / ﬂies were also sensitive to
osmotic stress and showed reduced survival compared to
w1118 control ﬂies when fed 500mM NaCl (Supplementary
Fig. 3B). Day 15 iPLA2-VIA / ﬂies also displayed
increased sensitivity to hypoxic and xenobiotic (dichlorodi-
phenyltrichloroethane, DDT) stresses (Supplementary Fig.
3C and D).
Loss of iPLA2-VIA was not associated
with changes in cardiolipin
composition
Given that mitochondrial membrane morphology appeared
to be abnormal in the iPLA2-VIA / ﬂies, we performed
mass spectroscopic analysis of cardiolipin, one of the major
phospholipids in mitochondrial membranes. It has been
hypothesized that PLA2G6 is critical for the normal
repair and remodelling of damage to cardiolipin caused
by mitochondrial reactive oxygen species, and that loss of
PLA2G6 activity may lead to cardiolipin oxidation and
pathogenic downstream events such as induction of apop-
tosis. To test this hypothesis, we performed mass spectro-
scopic analysis on iPLA2-VIA / ﬂy heads to compare the
cardiolipin composition with that in w1118 control ﬂies.
We found no signiﬁcant differences in the cardiolipin con-
tent, monolysocardiolipin content or fatty acid composition
between iPLA2-VIA / and control w1118 ﬂy brains
(Supplementary Fig. 4). Similar results have previously
been reported in whole ﬂies lacking iPLA2-VIA
(Malhotra et al., 2009). Furthermore, we found that oxi-
dized cardiolipin was not detected in signiﬁcant amounts in
either the iPLA2-VIA / or control w1118 ﬂy head hom-
ogenates (Supplementary Fig. 4). Oxidized cardiolipin
Figure 3 Flies lacking iPLA2-VIA have reduced mitochondrial membrane potential and decreased mitochondrial respiratory
chain activity. (A) The mitochondrial membrane potential measured using TMRM fluorescence in the brains of 25-day-old flies was significantly
decreased in iPLA2-VIA / brains compared to w1118 controls (***P5 0.001; n = 6 brains for each genotype). (B) The respiratory chain activity
was measured by assessing oxygen consumption and demonstrated that mitochondria from young Day 2 and old Day 32 iPLA2-VIA / flies have
reduced complex I and II–dependent respiration compared with w1118 control flies, manifested as significantly decreased oxygen consumption in
state 3 respiration (*P5 0.05, **P5 0.001). (C) The respiratory control ratio was significantly lower in iPLA2-VIA / mitochondria compared
with age-matched control w1118 mitochondria. Furthermore, the respiratory control ratio of iPLA2-VIA / flies in the presence of glutamate/
malate was dependent on the age of the flies: older flies having lower respiratory control ratio values (*P5 0.05, **P5 0.001).
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species would be expected to be present as additions of + 7/
8m/z on the scan spectra. Our results therefore do not
support a role for oxidized cardiolipin in causing mitochon-
drial dysfunction and neurodegeneration in ﬂies lacking
iPLA2-VIA activity.
Loss of iPLA2-VIA promotes brain lipid
peroxidation and reduces whole body
triacylglycerol levels
Despite the absence of changes in oxidized cardiolipin, we
hypothesized that loss of PLA2G6 may lead to abnormal
and excessive oxidation of other mitochondrial membrane
lipids, which in turn would lead to the observed mitochon-
drial dysfunction. We therefore studied the effect of knock-
ing out iPLA2-VIA on lipid peroxidation in Drosophila.
Rates of lipid peroxidation were measured by live imaging
of Day 25 iPLA2-VIA / and w1118 control dissected ﬂy
brains, using the ﬂuorescent ratiometric oxidation-sensitive
dye C11 BODIPY581/591, which shifts its ﬂuorescence
from red to green in a time-dependent manner, the rate
being proportional to levels of lipid peroxidation. The
changes in colour shift were detected by confocal micros-
copy. This demonstrated that levels of lipid peroxidation in
ﬂies lacking the iPLA2-VIA gene were 3.5-fold higher than
in age-matched control ﬂy brains (Fig. 5A).
There is evidence that PLA2G6 may play a role in the
regulation of triacylglycerol synthesis by providing
endogenous fatty acids (Gubern et al., 2009).
Triacylglycerol is the main form of lipid storage in the ﬂy
and therefore reﬂects the ability of ﬂies to respond to star-
vation conditions (Ballard et al., 2008). Measurement of
whole-body triacylglycerol levels in female ﬂies revealed a
signiﬁcant age-dependent reduction in both control w1118
and iPLA2-VIA / ﬂies. However, the reduction was
signiﬁcantly greater by Day 20 in the ﬂies lacking iPLA2-
VIA activity (Fig. 5B). In keeping with an age-dependent
decrease in triacylglycerol levels, iPLA2-VIA / ﬂies were
not sensitive to starvation conditions at Day 7 but became
sensitive at Day 15 compared with control w1118 ﬂies
(Fig. 5C).
Human mutant PLA2G6 fibroblasts
display abnormal mitochondrial
physiology
Given that loss of iPLA2-VIA led to increased lipid perox-
idation and mitochondrial dysfunction in Drosophila, we
examined ﬁbroblasts taken from a patient with a known
homozygous p.R747W mutation in PLA2G6 causing dys-
tonia-parkinsonism (Paisan-Ruiz et al., 2009). Using
TMRM ﬂuorescence to probe for mitochondrial membrane
potential, we found that there was a signiﬁcant decrease in
basal mitochondrial membrane potential in the mutant
human ﬁbroblasts (Fig. 6A and B), similar to that seen in
ﬂy brains lacking iPLA2-VIA.
Abnormal respiration and low mitochondrial membrane
potential can induce excessive reactive oxygen species pro-
duction in the matrix of mitochondria. Indeed the rate of
mitochondrial reactive oxygen species production, as
assessed using MitoSOX ﬂuorescence, was increased by
28% relative to control human ﬁbroblasts (Fig. 6C and
E). Cytosolic reactive oxygen species were also signiﬁcantly
higher in the ﬁbroblasts with a PLA2G6 mutation (Fig. 6D
and E).
Mutations in PLA2G6 are associated
with elevated mitochondrial lipid
peroxidation levels in human
fibroblasts and are reversed by
treatment with deuterated
polyunsaturated fatty acids
Following the demonstration that there is an increase in
lipid peroxidation in the brains of ﬂies lacking iPLA2-
VIA compared with controls, we also assessed lipid perox-
idation in two human PLA2G6 ﬁbroblast lines; one taken
Figure 4 iPLA2-VIA / flies have reduced ATP levels and are more sensitive to oxidative stress. (A) ATP levels are reduced in the
heads of Day 25 iPLA2-VIA / flies compared with age-matched w1118 control flies (*P5 0.05). (B) Aged Day 15 iPLA2-VIA / flies show reduced
survival when treated with 5% hydrogen peroxide (H2O2) (P = 5.6  107) and (C) 20 mM paraquat (P = 4.6  107) compared with w1118
control flies (n = 150 flies per genotype).
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from a patient with dystonia-parkinsonism with a
p.R747W mutation (Paisan-Ruiz et al., 2009) and the
other from a child with infantile neuroaxonal dystrophy.
We assessed lipid peroxidation levels using the ﬂuorescent
ratiometric oxidation-sensitive C11 BODIPY581/591 dye.
This demonstrated that PLA2G6 mutant ﬁbroblasts had
an increased level of lipid peroxidation compared to con-
trols (Fig. 7A), suggesting therefore that lipid peroxides
may be a potential therapeutic target.
Natural polyunsaturated fatty acids (PUFAs) such as lino-
leic acid undergo autoxidation by reactive oxygen species,
resulting in the production of toxic reactive carbonyl com-
pounds that can mediate DNA damage, carcinogenesis and
inﬂammation. However, replacement of the bis-allylic
hydrogen atoms with deuterium atoms (termed site-speciﬁc
isotope-reinforcement) arrests PUFA autoxidation due to
the isotope effect. Indeed, even small amounts of isotope-
reinforced D-PUFA are able to protect yeast from lipid aut-
oxidation-mediated cell killing (Hill et al., 2011, 2012).
These beneﬁts have also been conﬁrmed in vivo with the
demonstration that D-PUFAs reduce nigrostriatal degener-
ation in a mouse model of Parkinson’s disease (Shchepinov
et al., 2011). We therefore pretreated human PLA2G6
mutant ﬁbroblasts for 24 h with D-PUFA (D4-linoleic
acid) and found that this decreased lipid peroxidation in
the cells to below control levels (Fig. 7A). This was also
associated with a rescue in the reduced mitochondrial mem-
brane potential (Fig 7B). Moreover, assessment speciﬁcally
of lipid peroxidation levels in digitonin-permeabilized cells,
which destroys all cell membranes except mitochondrial
ones, also demonstrated that lipid peroxidation was sub-
stantially increased. In addition, when rotenone was added
to the ﬁbroblasts there was no further signiﬁcant increase in
the lipid peroxidation level, indicating that the lipid perox-
idation was predominantly produced by mitochondria in
the cell (Fig. 7C).
Deuterated linoleic acid partially
rescued the locomotor abnormalities
of flies lacking iPLA2-VIA
Finally, we tested the effect of inhibiting lipid peroxidation
with D-PUFAs on the neurodegenerative locomotor pheno-
type seen in ﬂies lacking iPLA2-VIA. Crosses for iPLA2-
VIA / and w1118 control ﬂies were set up on food
containing vehicle (H20), 10 or 100mM D2-linoleic acid.
Eclosed offspring were also kept on standard food contain-
ing either vehicle or D2-linoleic acid and aged while their
climbing ability was assessed. iPLA2-VIA / ﬂies treated
with 10 mM D2-linoleic acid had signiﬁcantly improved
motor performance in old age compared to ﬂies treated
with control food (Fig. 7D). There was a trend towards
improved climbing ability at older ages when iPLA2-
VIA / ﬂies were treated with 100mM D2-linoleic acid,
but this was not statistically signiﬁcant. The rescuing
effect of D2-linoleic acid on climbing ability was speciﬁc
to iPLA2-VIA / ﬂies, as the climbing ability of control
w1118 ﬂies treated with 10 mM D2-linoleic acid was indis-
tinguishable from controls (Supplementary Fig. 5B). The
effect of D2-linoleic acid on the survival of iPLA2-VIA
 /
ﬂies was also assessed. There was no signiﬁcant effect of
10mM D2-linoleic acid on the lifespan of ﬂies lacking
iPLA2-VIA. Indeed, at the higher concentration of 100mM
D2-linoleic, the lifespan of the iPLA2-VIA
 / ﬂies was
reduced compared to control w1118 ﬂies demonstrating that
D2-linoleic acid is toxic to ﬂies at higher concentrations
(Supplementary Fig. 5B). Despite the lack of lifespan-
prolonging effects, the fact that deuterated linoleic acid
signiﬁcantly improved the locomotor abnormalities of
iPLA2-VIA ﬂies suggests that low concentrations of
D-PUFAs, or similar compounds, may act as potential thera-
peutic compounds for the treatment of PLA2G6-associated
neurodegeneration.
Figure 5 Flies lacking iPLA2-VIA have increased lipid peroxidation in their brains and reduced triacylglycerol (TAG) levels.
(A) Lipid peroxidation was measured using C11-BODIPY581/591 and demonstrated that Day 25 iPLA2-VIA / fly brains have elevated levels of
lipid peroxidation compared with age-matched w1118 controls (n = 6 fly brains per experiment; **P5 0.01). (B) Whole-body triacylglycerol levels
are decreased in iPLA2-VIA / flies in an age-dependent manner compared with w1118 control flies. (***P = 0.005 Day 20 and *P = 0.01 Day 32).
(C) Day 15 iPLA2-VIA / flies are more sensitive to starvation conditions than age-matched w1118 control flies (P = 0.001; n = 150 flies per
genotype).
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Discussion
As the energy factories of cells, mitochondria play an es-
sential role in neurons, in which oxidative phosphorylation
is the main source of ATP. A previous study in a mouse
model demonstrated that knockout of Pla2g6 results in
abnormal mitochondrial membrane morphology (Beck
et al., 2011). These ﬁndings lead to the question as to
how loss of normal PLA2G6 gene function leads to abnor-
mal mitochondrial morphology, and whether mitochondrial
dysfunction is an early feature of PLA2G6-associated
neurodegeneration.
Figure 6 Human mutant PLA2G6 fibroblasts have reduced mitochondrial membrane potential and increased levels of mito-
chondrial and cytosolic reactive oxygen species levels. (A) The mitochondrial membrane potential of human p.R747W mutant PLA2G6
fibroblasts is reduced compared with control human fibroblasts (*P5 0.05 control 1 and **P5 0.002 control 2) as measured by TMRM fluor-
escence. (B) This is clearly seen as a reduction in red TMRM staining in the p.R747W mutant PLA2G6 human fibroblasts compared with control
fibroblasts (Scale bars = 44mm). (C) Mitochondrial reactive oxygen species production is increased 28% in human p.R747W mutant PLA2G6
fibroblasts compared to control fibroblasts (P5 0.001; n = 6). (D) Cytosolic reactive oxygen species production is also increased in human
p.R747W mutant PLA2G6 fibroblasts compared with control fibroblasts (1.47-fold increase; P5 0.001; n = 6). (E) Rates of reactive oxygen species
production in C and D are shown as a percentage. Het = dihydroethidium.
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Figure 7 Elevated lipid peroxidation is a possible therapeutic target in PLA2G6-associated disease. (A) Lipid peroxidation levels in
intact human fibroblasts taken from two patients with PLA2G6 mutations (mutant 1 fibroblasts were taken from a patient with a p.R747W PLA2G6
mutation and mutant 2 fibroblasts were from a patient with a PLA2G6 mutation and infantile neuroaxonal dystrophy) are increased compared with
fibroblasts from healthy controls. In addition, pretreatment with D-PUFAs (D4-linoleic acid) for 24 h significantly rescues the elevated lipid
peroxidation rates in the human PLA2G6 mutant fibroblasts (***P5 0.0001; n.s = non-significant). (B) The mitochondrial membrane potential of
human mutant PLA2G6 fibroblasts is considerably reduced compared with control fibroblasts and is significantly recovered below control levels
following 24 h pre-treatment with D4-linoleic acid (***P5 0.0001). (C) Lipid peroxidation levels are also increased in permeabilized mutant
p.R747W PLA2G6 fibroblasts compared with controls in the absence (***P5 0.05 for control 1 and control 2) and presence of rotenone
(***P5 0.05 for controls 1 and 2), suggesting that it is generated from a mitochondrial source. (D) Treatment of iPLA2-VIA / flies with 10mM D2-
linoleic acid partially rescues the climbing deficits in an age-dependent manner compared with untreated controls (n = 45 flies per group, three
repeats per group; one-way ANOVA with Bonferroni correction ***P5 0.003). There is a trend for 100 mM D2-linoleic acid to rescue the
climbing deficits of iPLA2-VIA / flies but this is not statistically significant. (E) Schematic diagram showing how loss of normal PLA2G6 activity
might lead to mitochondrial dysfunction. A mutation in PLA2G6 results in loss of PLA2G6 activity. In turn this results in elevated lipid peroxidation
of mitochondria, with the resultant decrease in mitochondrial membrane potential, decrease in ATP synthesis and mitochondrial reactive oxygen
species production. The mitochondria eventually degenerate and become swollen in appearance. All of these abnormalities result in mitochondrial
dysfunction and subsequent cellular dysfunction with consequent neuronal death. NBIA = neurodegeneration with brain iron accumulation;
ROS = reactive oxygen species.
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Loss of normal phospholipase A2
activity leads to mitochondrial
dysfunction, which precedes
mitochondrial membrane defects
In this study, we demonstrated that loss of normal
phospholipase A2 activity in the fruit ﬂy and in ﬁbroblasts
taken from patients harbouring mutations in PLA2G6,
results in striking abnormalities in both mitochondrial func-
tion and morphology. Furthermore, we demonstrate that
mitochondrial dysfunction precedes the mitochondrial mor-
phological abnormalities that are seen at the ultrastructural
level. Deﬁcits in mitochondrial oxidative respiration are
seen in iPLA2-VIA knockout ﬂies as young as 2 days of
age, when there are no associated mitochondrial membrane
abnormalities present on electron microscopy.
Moreover, our ﬁndings that mitochondrial dysfunction
occurs early in PLA2G6-associated neurodegeneration, is
consistent with the clinical features seen in infantile neu-
roaxonal dystrophy, neurodegeneration with brain iron
accumulation and dystonia-parkinsonism, all of which dis-
play clear early-onset phenotypes, that have previously
been associated with mitochondrial disease.
Loss of normal PLA2G6 activity
leads to reactive oxygen species
production
In addition to mitochondrial dysfunction, we also demon-
strate that loss of PLA2G6 activity is associated with raised
levels of reactive oxygen species. These species play import-
ant roles in cell signalling, but at abnormally high levels are
detrimental to cells, ultimately leading to cell death
(Martindale and Holbrook, 2002). Lipids are important
targets of reactive oxygen species and therefore elevated
reactive oxygen species levels will lead to increases in mito-
chondrial lipid peroxidation. Furthermore, it may also be
that elevated lipid peroxidation arises in the absence of
phospholipase A2 activity because some phospholipases
preferentially cleave oxidized lipids to maintain redox
homeostasis (Domijan et al., 2014). In turn, lipid peroxides
are known to trigger a cascade of events that include a fall
in mitochondrial membrane potential, mitochondrial swel-
ling and loss of mitochondrial matrix components (Castilho
et al., 1994). Furthermore, it has been shown that complex
I, the largest complex of the respiratory chain, is susceptible
to oxidative stress (Lin and Beal, 2006). Indeed we saw a
decrease in oxidative respiration in ﬂies lacking iPLA2-VIA
when we used substrates speciﬁc for complex I of the
respiratory chain. Furthermore, Lewy body disease has
been shown to be associated with reduced levels of com-
plex I activity (Gu et al., 1998), further implicating mito-
chondrial dysfunction in neurodegeneration, and more
speciﬁcally in PLA2G6-associated neurodegeneration,
which has been linked to parkinsonism and Lewy body
pathology.
In addition, lipid peroxidation is strongly catalysed
through the Fenton reaction by iron and iron complexes
(Koster et al., 1980) and it is iron that is often deposited in
the basal ganglia of the brains of patients affected with
PLA2G6 mutations (Morgan et al., 2006). Thus, iron-
mediated oxidative insults seem to have a crucial role in
the function of PLA2G6 and in the progression of diseases
associated with mutations in this gene.
PLA2G6-associated neurodegeneration
is not likely mediated by
oxidization of mitochondrial
cardiolipin
Given the increase in levels of lipid peroxidation in ﬂies
lacking iPLA2-VIA, we looked for elevated levels of oxi-
dized cardiolipin, one of the most common lipids in the
inner mitochondrial membrane. It has previously been
hypothesized that PLA2G6 is involved in the remodelling
of cardiolipin’s fatty acid side chains (Malhotra et al.,
2009) and in removing oxidized fatty acid side chains.
Oxidation of mitochondrial phospholipids such as cardio-
lipin leads to cytochrome c release and apoptosis (Kagan
et al., 2005). To determine whether cardiolipin is oxidized
in PLA2G6 loss-of-function, we analysed the cardiolipin
composition of iPLA2-VIA / ﬂy heads using mass spec-
trometry. We demonstrated that mitochondrial membrane
disintegration and mitochondrial dysfunction occur in the
absence of any signiﬁcant differences in cardiolipin amount
or side chain composition in ﬂy brains lacking iPLA2-VIA.
Furthermore, oxidized cardiolipin was not detected in sig-
niﬁcant amounts. This may be related to the types of fatty
acids present in Drosophila cardiolipin. Palmitic acid is the
major component of cardiolipin side chains in Drosophila
and is more resistant to oxidation than linoleic acid, the
main cardiolipin side chain in most mammalian tissues.
However, it could also point towards redundancy in the
cardiolipin remodelling enzymes. There are a number of
enzymes involved in cardiolipin remodelling and it may
be the case that fatty acid remodelling of the side chains,
in particular removal of oxidized fatty acids, can be
performed by other enzymes involved in cardiolipin remo-
delling such as tafazzin (Schlame, 2013).
The abnormal lipid peroxidation seen
in PLA2G6 knockout leads to a toxic
cascade of downstream events
In this work we report that loss of normal PLA2G6 func-
tion is strongly associated with elevated mitochondrial lipid
peroxidation. Furthermore lipid peroxidation is known to
induce mitochondrial injury, leading to a decrease in oxi-
dative respiratory chain function, reduced mitochondrial
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membrane potential, reduced cellular ATP levels and raised
reactive oxygen species levels, all features we have demon-
strated in ﬂies and human ﬁbroblasts lacking normal
PLA2G6 gene activity (Fig. 7D). This in turn would be
predicted to lead to cell death and neurodegeneration. As
lipid peroxides are harmful mediators of oxidative stress,
strategies focused on quenching, recycling or protecting
such products could be highly effective in the treatment
of the disease.
This work suggests that lipid peroxi-
dation-lowering strategies may be
beneficial in PLA2G6-associated
neurodegeneration
In addition to showing that lipid peroxidation is increased
in both ﬂy brains lacking iPLA2-VIA and human PLA2G6
mutant ﬁbroblasts, we have demonstrated that D-PUFAs
reduce the rates of lipid peroxidation in two lines of
PLA2G6 mutant ﬁbroblasts and restore mitochondrial
membrane potential. This suggests that D-PUFAs may
have potential therapeutic roles in PLA2G6-associated
neurodegeneration and its associated mitochondrial
dysfunction.
Our data promote Drosophila as a useful model for
studying PLA2G6-associated neurodegeneration, and for
manipulating pathways and therapeutic targets in order
to reverse or prevent the deleterious effects of lipid perox-
ides. Loss of iPLA2-VIA gene function results in reduced
lifespan and locomotor ability, increased sensitivity to oxi-
dative insults as well as hypoxia, osmotic and starvation
stressors. Thus ﬂies lacking iPLA2-VIA display phenotypes
that can be used as markers in genetic modifying screens or
in the screening of potential therapeutic compounds. To
test the validity of the ﬂy model for drug screening and
to conﬁrm the beneﬁts of D-PUFAs in vivo in an organism
lacking iPLA2-VIA, we examined the effects of D-PUFAs
on the locomotor deﬁcits of iPLA2-VIA / ﬂies. This
demonstrated that treatment with D2-linoleic acid partially
rescues the climbing abnormalities in aged iPLA2-VIA
knockout ﬂies. Therefore this approach of using com-
pounds, which act to reduce the autoxidation of lipids,
may represent a future therapeutic strategy for patients
with PLA2G6-associated neurodegeneration and warrants
further investigation.
Acknowledgements
We would like to thank Drs Fiona Kerr, Teresa Niccoli,
Nazif Alic and Ekin Bolukbasi for technical advice and
useful discussions, and Filiz Senbabaoglu and Helena
Cantwell for technical assistance. We also thank Kerrie
Venner for help with electron microscopy and Dr Una
Sheerin for help with patient ﬁbroblast sample collection.
We also thank the TRiP at Harvard Medical School (NIH/
NIGMS R01-GM084947) for providing a transgenic RNAi
ﬂy stock used in this study, and Dr Mikhail S. Shchepinov
(Retrotope, Inc) for providing D-PUFAs.
Funding
K.J.K, L.P. and J.H. are funded by the Wellcome Trust.
F.B. is supported by a fellowship from the Spanish
Ministerio de Educacion through the FECYT and partially
supported by an ALS Association Initiated award (ID
2109) and Motor Neuron Disease Association Small
Grants (Hardy/Oct12/6603). L.P. is also supported by the
Max Planck Society. This work was also supported by the
Welcome Trust MRC strategic neurodegenerative disease
initiative award (Ref. number WT089698). K.J.K. was the
recipient of a post-doctoral Wellcome Trust fellowship
(Ref. number 090541/Z/09/Z). Part of this work was
undertaken at the University College of London Hospitals
who received a proportion of their funding from the
Department of Health’s NIHR Biomedical Research
Centres funding scheme. K.B.B. was also funded by a
Parkinson’s UK Grant (Ref. number G-1009). L.L. is also
the recipient of a Parkinson’s UK PhD studentship (Ref.
number H-1105).
Supplementary material
Supplementary material is available at Brain online.
References
Ballard JW, Melvin RG, Simpson SJ. Starvation resistance is positively
correlated with body lipid proportion in ﬁve wild caught Drosophila
simulans populations. J Insect Physiol 2008; 54: 1371–6.
Brand AH, Perrimon N. Targeted gene expression as a means of alter-
ing cell fates and generating dominant phenotypes. Development
1993; 118: 401–15.
Beck G, Sugiura Y, Shinzawa K, Kato S, Setou M, Tsujimoto Y, et al.
Neuroaxonal dystrophy in calcium-independent phospholipase A2b
deﬁciency results from insufﬁcient remodeling and degeneration of
mitochondrial and presynaptic membranes. J Neurosci 2011; 31:
11411–20.
Castilho RF, Meinicke AR, Almeida AM, Hermes-Lima M, Vercesi
AE. Oxidative damage of mitochondria induced by Fe (II) citrate
is potentiated by Ca2 + and includes lipid peroxidation and alter-
ations in membrane proteins. Arch Biochem Biophys 1994; 308:
158–63.
Chance B, Williams GR. A simple and rapid assay of oxidative phos-
phorylation. Nature 1955; 175: 1120–1.
Cheon Y, Kim HW, Igarashi M, Modi HR, Chang L, Ma K, et al.
Disturbed brain phospholipid and docosahexaenoic acid metabolism
in calcium-independent phospholipase A(2)-VIA (iPLA(2)b)-
knockout mice. Biochim Biophys Acta 2012; 1821: 1278–86.
Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH, et al.
Drosophila pink1 is required for mitochondrial function and inter-
acts genetically with parkin. Nature 2006; 441: 1162–6.
The role of PLA2G6 in mitochondrial disease BRAIN 2015: 138; 1801–1816 | 1815
Domijan AM, Kovac S, Abramov AY. Lipid peroxidation is essential
for phospholipase C activity and the inositol-trisphosphate-related
Ca2+ signal. J Cell Sci 2014; 127: 21–6.
Engel LA, Jing Z, O’Brien DE, Sun M, Kotzbauer PT. Catalytic func-
tion of PLA2G6 is impaired by mutations associated with infantile
neuroaxonal dystrophy but not dystonia-parkinsonism. PLoS One
2010; 5: e12897.
Gadd ME, Broekemeier KM, Crouser ED, Kumar J, Graff G, Pfeiffer
DR. Mitochondrial iPLA2 activity modulates the release of cyto-
chrome c from mitochondria and inﬂuences the permeability transi-
tion. J Biol Chem 2006; 281: 6931–9.
Gregory A, Westaway SK, Holm IE, Kotzbauer PT, Hogarth P, Sonek
S, et al. Neurodegeneration associated with genetic defects in
phospholipase A(2). Neurology 2008; 71: 1402–9.
Gu M, Owen AD, Toffa SE, Cooper JM, Dexter DT, Jenner P, et al.
Mitochondrial function, GSH and iron in neurodegeneration and
Lewy body diseases. J Neurol Sci 1998; 158: 24–9.
Gubern A, Barcelo´-Torns M, Casas J, Barneda D, Masgrau R,
Picatoste F, et al. Lipid droplet biogenesis induced by stress involves
triacylglycerol synthesis that depends on group VIA phospholipase
A2. J Biol Chem 2009; 284: 5697–708.
Gui YX, Xu ZP, Wen-Lv, Liu HM, Zhao JJ, Hu XY. Four novel rare
mutations of PLA2G6 in Chinese population with Parkinson’s dis-
ease. Parkinsonism Related Disord 2013; 19: 21–6.
Hill S, Lamberson CR, Xu L, To R, Tsui HS, Shmanai VV, et al. Small
amounts of isotope-reinforced polyunsaturated fatty acids suppress
lipid autoxidation. Free Radic Biol Med 2012; 53: 893–906.
Hill S, Hirano K, Shmanai VV, Marbois BN, Vidovic D, Bekish AV,
et al. Isotope-reinforced polyunsaturated fatty acids protect yeast
cells from oxidative stress. Free Radic Biol Med 2011; 50: 130–8.
Heather LC, Carr CA, Stuckey DJ, Pope S, Morten KJ, Carter EE,
et al. Critical role of complex III in the early metabolic changes
following myocardial infarction. Cardiovasc Res 2010; 85: 127–36.
Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA,
et al. Cytochrome c acts as a cardiolipin oxygenase required for
release of proapoptotic factors. Nat Chem Biol 2005; 1: 223–32.
Khateeb S, Flusser H, Oﬁr R, Shelef I, Narkis G, Vardi G, et al.
PLA2G6 mutation underlies infantile neuroaxonal dystrophy. Am
J Hum Genet 2006; 79: 942–8.
Koster JF, Slee RG. Lipid peroxidation of rat liver microsomes.
Biochim Biophys Acta 1980; 620: 489–99.
Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in
neurodegenerative diseases. Nature 2006; 443: 787–95.
Ma Z, Turk J. The molecular biology of the group VIA Ca2+ -inde-
pendent phospholipase A2. Prog Nucleic Acid Res Mol Biol 2001;
67: 1–33.
Malhotra A, Edelman-Novemsky I, Xu Y, Plesken H, Ma J, Schlame
M, et al. Role of calcium-independent phospholipase A2 in the
pathogenesis of Barth syndrome. Proc Natl Acad Sci USA 2009;
106: 2337–41.
Martindale JL, Holbrook NJ. Cellular response to oxidative stress:
signaling for suicide and survival. J Cell Physiol 2002; 192: 1–15.
Miwa S, St-Pierre J, Partridge L, Brand MD. Superoxide and hydrogen
peroxide production by Drosophila mitochondria. Free Radic Biol
Med 2003; 35: 938–48.
Morgan NV, Westaway SK, Morton JE, Gregory A, Gissen P, Sonek
S, et al. PLA2G6, encoding a phospholipase A2, is mutated in
neurodegenerative disorders with high brain iron. Nat Genet
2006; 38: 752–4.
Paisan-Ruiz C, Bhatia KP, Li A, Hernandez D, Davis M, Wood NW,
et al. Characterization of PLA2G6 as a locus for dystonia-
parkinsonism. Ann Neurol 2009; 65: 19–23.
Paisan-Ruiz C, Li A, Schneider SA, Holton JL, Johnson R, Kidd D,
et al. Widespread Lewy body and tau accumulation in childhood
and adult onset dystonia-parkinsonism cases with PLA2G6 muta-
tions. Neurobiol Aging 2012; 33: 814–23.
Park J, Lee SB, Lee S, Kim Y, Song S, Kim S, et al. Mitochondrial
dysfunction in Drosophila PINK1 mutants is complemented by
parkin. Nature 2006; 441: 1157–61.
Pope S, Land JM, Heales SJ. Oxidative stress and mitochondrial dys-
function in neurodegneration: cardiolpin a critical target? Biochim
Biophys Acta 2008; 1777: 794–9.
Rival T, Soustelle L, Strambi C, Besson MT, Iche M, Birman S.
Decreasing glutamate buffering capacity triggers oxidative stress
and neuropil degeneration in the Drosophila brain. Curr Biol
2004; 14: 599–605.
Rodriguez-Cuenca S, Cocheme´ HM, Logan A, Abakumova I, Prime
TA, Rose C, et al. Consequences of long-term oral administration of
the mitochondria-targeted antioxidant Mito Q to wild-type mice.
Free Radic Biol Med 2010; 48: 161–72.
Schaeffer EL, Gattaz WF. Cholinergic and glutamatergic alterations
beginning at the early stages of Alzheimer disease: participation of
the phospholipase A2 enzyme. Psychopharmacology (Berl) 2008;
198: 1–27.
Shchepinov MS, Chou VP, Pollock E, Langston JW, Cantor CR,
Molinari RJ, et al. Isotopic reinforcement of essential polyunsatur-
ated fatty acids diminishes nigrostriatal degeneration in a mouse
model of Parkinson’s disease. Toxicol Lett 2011; 207: 97–103.
Schlame M. Cardiolipin remodeling and the function of tafazzin.
Biochim Biophys Acta 2013; 1831: 582–8.
Seleznev K, Zhao C, Zhang XH, Song K, Ma ZA. Calcium-independ-
ent phospholipase A2 localizes in and protects mitochondria during
apoptotic induction by staurosporine. J Biol Chem 2006; 281:
22275–88.
Strokin M, Seburn KL, Cox GA, Martens KA, Reiser G. Severe dis-
turbance in the Ca2+ signaling in astrocytes from mouse models of
human infantile neuroaxonal dystrophy with mutated Pla2g6. Hum
Mol Genet 2012; 21: 2807–14.
Vaarmann A, Gandhi S, Abramov AY. Dopamine induces Ca2 + sig-
naling in astrocytes through reactive oxygen species generated by
monoamine oxidase. J Biol Chem 2010; 285: 25018–23.
Wolf MJ, Gross RW. Expression, puriﬁcation, and kinetic character-
ization of a recombinant 80-kDa intracellular calcium-independent
phospholipase A2. J Biol Chem 1996; 271: 30879–85.
Xu C, Warsh JJ, Wang KS, Mao CX, Kennedy JL. Association of the
iPLA2b gene with bipolar disorder and assessment of its interaction
with TRPM2 gene polymorphisms. Psychiatr Genet 2013; 23: 86–9.
Zhao Z, Wang J, Zhao C, Bi W, Yue Z, Ma ZA. Genetic ablation of
PLA2G6 in mice leads to cerebellar atrophy characterized by
Purkinje cell loss and glial cell activation. PLoS One 2011; 6:
e26991.
1816 | BRAIN 2015: 138; 1801–1816 K. J. Kinghorn et al.
